Unit of Medical Psychology, Department of Clinical and Experimental Medicine, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
Department of Paediatrics and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Int J Dermatol. 2017 Dec;56(12):1387-1394. doi: 10.1111/ijd.13739. Epub 2017 Sep 27.
Individuals with body dysmorphic disorder (BDD) are highly distressed and impaired owing to perceived defects in their physical appearance that are not noticeable to others. They are frequently concerned about their skin and often present to dermatologists rather than psychiatrists. However, BDD patients attending dermatology clinics may be at risk of not receiving an appropriate assessment and beneficial treatment. The aims of this study were to estimate the BDD prevalence rate among Swedish female dermatology patients and to assess the psychological condition of BDD patients compared to that of other dermatology patients.
The occurrence of BDD was estimated using the Body Dysmorphic Disorder Questionnaire (BDDQ), a validated self-report measure for BDD. Symptoms of depression and anxiety were measured by the Hospital Anxiety and Depression Scale (HADS), and quality of life was assessed using the Dermatology Life Quality Index (DLQI).
The prevalence rate of BDD among female Swedish dermatology patients was 4.9% (95% CI 3.2-7.4). Anxiety (HADS A ≥ 11) was 4-fold more commonly reported by patients with positive BDD screening (48% vs. 11%), and depression (HADS D ≥ 11) was over 10-fold more common in patients with positive BDD screening (19% vs. 1.8%) (P < 0.001). The median DLQI score was 18 in the BDD group, compared to a score of 4 in the non-BDD group (P < 0.001).
Our results indicate that BDD is fairly common among female Swedish dermatology patients (4.9%) and that BDD patients have high levels of depression and anxiety and severely impaired quality of life.
由于个体对自身外貌的感知缺陷(这种缺陷在他人看来并不明显),患有躯体变形障碍(BDD)的个体感到高度痛苦和受损。他们通常对自己的皮肤感到担忧,经常去看皮肤科医生而不是精神科医生。然而,在皮肤科诊所就诊的 BDD 患者可能存在未得到适当评估和有益治疗的风险。本研究的目的是估计瑞典女性皮肤科患者中的 BDD 患病率,并评估 BDD 患者的心理状况与其他皮肤科患者的差异。
使用躯体变形障碍问卷(BDDQ)来估计 BDD 的发生情况,BDDQ 是一种用于 BDD 的经过验证的自评量表。使用医院焦虑和抑郁量表(HADS)来测量抑郁和焦虑症状,使用皮肤病生活质量指数(DLQI)来评估生活质量。
瑞典女性皮肤科患者中 BDD 的患病率为 4.9%(95%CI 3.2-7.4)。有阳性 BDD 筛查结果的患者中焦虑(HADS A≥11)的报告比例高出 4 倍(48% vs. 11%),而有阳性 BDD 筛查结果的患者中抑郁(HADS D≥11)的报告比例高出 10 倍以上(19% vs. 1.8%)(P<0.001)。BDD 组的中位数 DLQI 评分为 18,而非 BDD 组为 4(P<0.001)。
我们的研究结果表明,BDD 在瑞典女性皮肤科患者中相当常见(4.9%),且 BDD 患者存在严重的抑郁和焦虑,生活质量严重受损。